The headline result was materially below what the market expected. Q2 diluted EPS was $4.73 versus published consensus of about $5.63, while revenue was $2.22 billion versus roughly $2.45 billion expected — misses of approximately 16% and 9%, respectively.
| Metric | Q2 2025 | Q2 2026 | Published expectation |
|---|---|---|---|
| Net sales | $1.890B *(Financial results — second quarter and first half 2026)* | $2.222B *(Financial results — second quarter and first half 2026)* | ~$2.45B |
| Net earnings attributable to common stockholders | $386M *(Financial results — second quarter and first half 2026)* | $727M *(Financial results — second quarter and first half 2026)* | — |
| Diluted EPS | $2.37 *(Financial results — second quarter and first half 2026)* | $4.73 *(Financial results — second quarter and first half 2026)* | ~$5.63 |
| Adjusted EBITDA | $761M *(Financial results — second quarter and first half 2026)* | $1.192B *(Financial results — second quarter and first half 2026)* | — |
| Capital expenditures | $232M *(Financial results — second quarter and first half 2026)* | $215M *(Financial results — second quarter and first half 2026)* | — |
Pricing was genuinely strong, but it was not enough to overcome weaker volumes. The company’s bridge shows a $588 million year-over-year adjusted-EBITDA benefit from price, partly offset by a $158 million volume headwind; realized gas costs contributed only $3 million. That means the earnings improvement was driven primarily by nitrogen pricing rather than broader operating growth. *(Q2 2026 vs. Q2 2025 Adjusted EBITDA bridge)*
The filing still supports a favorable industry backdrop, but the near-term operating picture is less clean. CF achieved 98% available ammonia-capacity utilization in the first half, and it expects tight nitrogen supply-demand conditions to persist into 2027. However, 2026 gross ammonia production remains constrained at approximately 9.5 million tons by the Yazoo City outage, with the complex not expected to resume production until the first half of 2027. *(Highlights and Outlook; Nitrogen Market Outlook)*
Blue Point advanced, but it is a future growth investment rather than a current-quarter earnings offset. Permits were received in July and construction is scheduled to begin in August, with CF estimating a $1.5 billion contribution plus $550 million for common facilities. The project is strategically meaningful, but it also sits inside a roughly $950 million 2026 CF-funded capital-expenditure plan, including about $400 million for Blue Point. *(Blue Point reaches key milestone; Highlights and Outlook)*
Net read: operationally solid, expectation-wise disappointing. Adjusted EBITDA nearly doubled year over year and cash generation remained substantial, with $1.823 billion of Q2 2026 LTM free cash flow and $302 million returned to shareholders in Q2. But those strengths were already less important than whether earnings cleared the elevated bar implied by consensus; they did not. The quarter therefore lands as a significant negative versus expectations, with strong pricing and strategic progress outweighed by the revenue, EPS, and volume shortfalls. *(Non-GAAP reconciliation of cash from operations to free cash flow; Highlights and Outlook)*
Read the original 8-K on SEC EDGAR ↗